U.S. Physical Therapy Inc. Hits New 52-Week High at $32.34 (USPH)
U.S. Physical Therapy (NASDAQ:USPH) set a new 52-week high during mid-day trading on Wednesday, AnalystRatings.Net reports. The stock traded as high as $32.34 and last traded at $32.17, with a volume of 49,823 shares. The stock had previously closed at $31.75.
USPH has been the subject of a number of recent research reports. Analysts at Noble Financial downgraded shares of U.S. Physical Therapy (NASDAQ:USPH) from a “buy” rating to a “hold” rating in a research note to investors on Wednesday. They now have a $33.00 price target on the stock, up previously from $32.00. Finally, analysts at Dougherty & Co raised their price target on shares of U.S. Physical Therapy (NASDAQ:USPH) from $30.00 to $35.00 in a research note to investors on Friday, August 23rd. They now have a “buy” rating on the stock.
U.S. Physical Therapy has a 52-week low of $22.69 and a 52-week high of $32.37. The stock’s 50-day moving average is $29. and its 200-day moving average is $27.88. The company has a market cap of $388.0 million and a price-to-earnings ratio of 22.05.
U.S. Physical Therapy (NASDAQ:USPH) last released its earnings data on Thursday, August 8th. The company reported $0.41 EPS for the quarter, missing the Thomson Reuters consensus estimate of $0.42 by $0.01. The company had revenue of $67.22 million for the quarter, compared to the consensus estimate of $66.49 million. During the same quarter in the prior year, the company posted $0.41 earnings per share. The company’s quarterly revenue was up 5.1% on a year-over-year basis. Analysts expect that U.S. Physical Therapy will post $1.51 EPS for the current fiscal year.
U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical and occupational therapy clinics that provide pre- and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.